To evaluate the predictive value of D-dimer level for stroke , other cardiovascular events , and bleeds , in patients with atrial fibrillation ( AF ) treated with oral anticoagulation with apixaban or warfarin ; and to evaluate the relationship between the D-dimer levels at baseline and the treatment effect of apixaban vs. warfarin .